Search

everythinglearnresearchcommunity

for

Search:↓

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Overactive Wnt signaling in mouse skin stem cells causes acne-like cysts and shrinking oil glands, which some treatments can partially fix.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

The study found that a specific area of the hair follicle helps start hair growth by reducing the blocking effects on certain cells and controlling growth signals.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Understanding hair follicle development helps create treatments for hair loss and improve hair health.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Lhx2 is essential for effective Sonic Hedgehog signaling in early retinal development.

The Shh gene controls cell growth and death in cashmere goat hair follicles, affecting hair growth.

Epidermal β-catenin activation changes the dermis by signaling different fibroblast types.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Overactive sonic hedgehog signaling worsens uterine scarring by reducing cell recycling.